Enovis Corporation
Enovis Corporation (ENOV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ENOV · as of Jun 8, 2026
Key Statistics
Explore Enovis Corporation Data
enov stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 76.9%
The ENOV analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $45.80, representing +92.60% upside from the current price of $23.78.
Competitors & Peers
enov competitorsENOV
DCI
EPAC
FELE
GHM
GRCStock Performance
Full HistoryAbout Enovis Corporation
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physici…
what is enovis corporation · enov stock overview · enovis corporation company profile · who is enovis corporation ceo · enov NYSE · enovis corporation headquarters · enovis corporation business segments
About Stock Overview & Key Data
Enovis Corporation (ENOV) is a Healthcare company in the Medical - Devices industry, listed on NYSE since May 8, 2008. As of the latest trading session, ENOV stock price is $23.78, with a market capitalization of $1.4B. The stock has returned -27.70% over the past 12 months and -10.74% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Enovis Corporation stock is Buy, with an average 12-month price target of $45.80. In fiscal year 2025, Enovis Corporation reported revenue of $2.2B and net income of -$1.2B. For detailed data — including Enovis Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Enovis Corporation (ENOV) stock price is $23.78. The stock is traded on NYSE under the ticker symbol ENOV. The 52-week range is $20.82 – $36.82.